| Title | PMID |
| Hydroxylated collagen peptide in urine as biomarker for detecting colorectal liver metastases. | 27186406 |
| Profiling of Cross-Functional Peptidases Regulated Circulating Peptides in BRCA1 Mutant Breast Cancer. | 27058005 |
| Identification of Serum Peptidome Signatures of Non-Small Cell Lung Cancer. | 27043541 |
| Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study. | 27026199 |
| Novel circulating peptide biomarkers for esophageal squamous cell carcinoma revealed by a magnetic bead-based MALDI-TOFMS assay. | 26993605 |
| High-sensitivity HLA class I peptidome analysis enables a precise definition of peptide motifs and the identification of peptides from cell lines and patients' sera. | 26992070 |
| Identification of haptoglobin peptide as a novel serum biomarker for lung squamous cell carcinoma by serum proteome and peptidome profiling. | 26783151 |
| Identification of novel serum peptides biomarkers for female breast cancer patients in Western China. | 26705257 |
| Identification of carboxyl terminal peptide of Fibrinogen as a potential serum biomarker for gastric cancer. | 26662807 |
| Tumor size, stage and grade alterations of urinary peptidome in RCC. | 26482227 |
| Alterations of the Plasma Peptidome Profiling in Colorectal Cancer Progression. | 26379225 |
| Identification of serum proteome signatures of locally advanced and metastatic gastric cancer: a pilot study. | 26376850 |
| Serum peptidome profiling analysis for the identification of potential biomarkers in cervical intraepithelial neoplasia patients. | 26282206 |
| Serum peptidome patterns of hepatocellular carcinoma based on magnetic bead separation and mass spectrometry analysis. | 25910294 |
| Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma. | 25368985 |
| The C-terminal fragment of prostate-specific antigen, a 2331 Da peptide, as a new urinary pathognomonic biomarker candidate for diagnosing prostate cancer. | 25233230 |
| Liquid chromatography-mass spectrometry based serum peptidomic approach for renal clear cell carcinoma diagnosis. | 25168216 |
| Deciphering the peptidome of urine from ovarian cancer patients and healthy controls. | 24982608 |
| Deciphering the ovarian cancer ascites fluid peptidome. | 24694173 |
| Identification alpha-2-HS-glycoprotein precursor and tubulin beta chain as serology diagnosis biomarker of colorectal cancer. | 24618180 |
| Novel alternative splicing isoform biomarkers identification from high-throughput plasma proteomics profiling of breast cancer. | 24565027 |
| Detection of cervical cancer biomarker patterns in blood plasma and urine by differential scanning calorimetry and mass spectrometry. | 24416269 |
| Comparative serum proteomic analysis of serum diagnosis proteins of colorectal cancer based on magnetic bead separation and maldi-tof mass spectrometry. | 24289627 |
| Biomarkers screening between preoperative and postoperative patients in pancreatic cancer. | 23991970 |
| Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling. | 23915341 |
| Serum peptidome patterns of hepatocellular carcinoma based on magnetic bead separation and mass spectrometry analysis. | 23915185 |
| Peptidome analysis of human skim milk in term and preterm milk. | 23891694 |
| Serum peptidome variations in a healthy population: reference to identify cancer-specific peptides. | 23667664 |
| Serum peptidome patterns for early screening of esophageal squamous cell carcinoma. | 23586861 |
| Serum peptidome patterns of colorectal cancer based on magnetic bead separation and MALDI-TOF mass spectrometry analysis. | 23091368 |
| Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients. | 22942358 |
| Toward a standardized saliva proteome analysis methodology. | 22809520 |
| Identification of novel low molecular weight serum peptidome biomarkers for non-small cell lung cancer (NSCLC). | 22628229 |
| Serum peptidome patterns of breast cancer based on magnetic bead separation and mass spectrometry analysis. | 22521044 |
| Early detection of ovarian cancer in samples pre-diagnosis using CA125 and MALDI-MS peaks. | 22086897 |
| Assessment of high-throughput high-resolution MALDI-TOF-MS of urinary peptides for the detection of muscle-invasive bladder cancer. | 21805675 |
| Serum peptidome profiling in patients with gastric cancer. | 21739109 |
| Human urinary peptide database for multiple disease biomarker discovery. | 21591268 |
| [Establishment of a specific serum proteomic profile model of nasopharyngeal carcinoma by MALDI-TOF MS]. | 21575517 |
| A comprehensive peptidome profiling technology for the identification of early detection biomarkers for lung adenocarcinoma. | 21533267 |
| Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assays. | 21267442 |
| The absolute quantification of eight inter-α-trypsin inhibitor heavy chain 4 (ITIH4)-derived peptides in serum from breast cancer patients. | 21137033 |
| Specific Investigation of Sample Handling Effects on Protease Activities and Absolute Serum Concentrations of Various Putative Peptidome Cancer Biomarkers. | 21124649 |
| Serum peptidome profiling in patients with lung cancer. | 21082738 |
| Soluble plasma HLA peptidome as a potential source for cancer biomarkers. | 20974924 |
| Finding new posttranslational modifications in salivary proline-rich proteins. | 20879038 |
| Analysis of the plasma peptidome from pancreas cancer patients connects a peptide in plasma to overexpression of the parent protein in tumors. | 19795908 |
| Macrophage migration inhibitory factor anti-thrombin III complexes are decreased in bladder cancer patient serum: Complex formation as a mechanism of inactivation. | 19762145 |
| Prediction of outcome of non-small cell lung cancer patients treated with chemotherapy and bortezomib by time-course MALDI-TOF-MS serum peptide profiling. | 19728888 |
| Peptide screening of cerebrospinal fluid in patients with glioblastoma multiforme. | 19674866 |
| An integrated LC-ESI-MS platform for quantitation of serum peptide ladders. Application for colon carcinoma study. | 21136997 |
| Selective on-line serum peptide extraction and multidimensional separation by coupling a restricted-access material-based capillary trap column with nanoliquid chromatography-tandem mass spectrometry. | 19482289 |
| Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer. | 19470732 |
| Evaluation of endogenous plasma peptide extraction methods for mass spectrometric biomarker discovery. | 17269714 |
| Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age. | 16896061 |
| Differential exoprotease activities confer tumor-specific serum peptidome patterns. | 16395409 |